Novo Nordisk to acquire US drug delivery company Emisphere Technologies
Danish pharma company Novo Nordisk has agreed to acquire US drug delivery company Emisphere Technologies in a deal worth $1.8 billion. The proprietary drug delivery technologies of Emisphere Technologies include the Eligen SNAC technology and others which enable oral formulations of therapeutics. Since 2007, Novo Nordisk and the US company have collaborated. Eligen SNAC is […]